Magnetar Financial’s Apellis Pharmaceuticals APLS Stock Holding History

Magnetar Financial’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-869,229	Closed	-$35M	–	1162
2026 Q1	$35M	Buy	+869,229	New	+$18.7M	0.36%	34
2022 Q2	–	Sell	-9,532	Closed	-$484K	–	1667
2022 Q1	$484K	Sell	9,532 -3,009	-24%	-$133K	0.01%	920
2021 Q4	$593K	Buy	+12,541	New	+$494K	0.01%	931

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Magnetar Financial's APLS Position: Q2 2026 in Review

Magnetar Financial sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 869,229 shares — an estimated $35M sold.

Magnetar Financial first reported a position in APLS in Q4 2021 and held it in 3 quarters. The position peaked at $35M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Magnetar Financial reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Magnetar Financial sold 869,229 Apellis Pharmaceuticals shares in Q2 2026, an estimated $35M.
Magnetar Financial first reported a position in Apellis Pharmaceuticals in Q4 2021 and held it in 3 quarters.
Magnetar Financial's Apellis Pharmaceuticals position peaked at $35M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.